Stanford study finds that whole-genome sequencing for clinical use faces many challenges

Stanford study finds that whole-genome sequencing for clinical use faces many challenges Whole-genome sequencing is a powerful technology, but a new Stanford study shows that significant challenges must be overcome before it can be routinely clinically useful. Click here to read the full press release. ### Among the research institutions NCI funds across the United … Continue reading “Stanford study finds that whole-genome sequencing for clinical use faces many challenges”

Stanford study finds that whole-genome sequencing for clinical use faces many challenges

Whole-genome sequencing is a powerful technology, but a new Stanford study shows that significant challenges must be overcome before it can be routinely clinically useful.

Click here to read the full press release.

###

Among the research institutions NCI funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.

Author: Joe Lovrek

Born in Houston, Raised in Trinity Texas

Leave a Reply